Baltimore, MD, United States of America

Vu L Truong

This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Johns Hopkins University. Active years: 1999-2002.


% Patents Active = 100.0


 

Average Co-Inventor Count = 3.5

ph-index = 3

Forward Citations = 85(Granted Patents)


Company Filing History:


Years Active: 1999-2002

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Vu L Truong

Introduction

Vu L Truong is an accomplished inventor based in Baltimore, MD (US). He has made significant contributions to the field of gene delivery systems, holding a total of three patents. His work focuses on developing targeted gene delivery systems that enhance the effectiveness of genetic therapies.

Latest Patents

One of his latest patents is a targeted gene delivery system that utilizes enzymatically degradable gelatin and nucleic acids (DNA or RNA) microparticles. This innovative system features a linking moiety or a targeting ligand attached to the surface, allowing for a simple method of production. The design enables the attachment of various molecules, including antibodies, cell adhesion molecules, hormones, and other cell-specific ligands. Another notable patent is for solid microparticles for gene delivery, which shares similar characteristics and applications as his targeted gene delivery system.

Career Highlights

Vu L Truong is affiliated with The Johns Hopkins University, where he continues to advance his research in gene delivery technologies. His work has the potential to revolutionize the way genetic therapies are administered, making them more precise and effective.

Collaborations

He collaborates with esteemed colleagues such as Thomas August and Kam W Leong, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Vu L Truong's contributions to the field of gene delivery systems exemplify the impact of innovative thinking in medical science. His patents reflect a commitment to improving therapeutic techniques and advancing the frontiers of genetic research.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…